Chlorthalidone NDC 68788-4077

NDC codes

FDA NDC Directory

Product NDC (as listed)68788-4077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68788-4077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68788-4077-3	68788407703	30 TABLET in 1 BOTTLE, PLASTIC (68788-4077-3)Marketed from Feb 17, 2026
68788-4077-9	68788407709	90 TABLET in 1 BOTTLE, PLASTIC (68788-4077-9)Marketed from Feb 17, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Chlorthalidone
Generic name (nonproprietary): chlorthalidone
Active ingredients: Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Preferred Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211627
Marketing start: Feb 17, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Increased Diuresis (Physiologic effect)
Identifiers: Product ID 68788-4077_db169e46-9f6e-490e-856f-f60ec9a31980SPL ID db169e46-9f6e-490e-856f-f60ec9a31980SPL set ID db169e46-9f6e-490e-856f-f60ec9a31980RxCUI 197499UNII Q0MQD1073Q
Pharmacologic class: Thiazide-like Diuretic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468788407703 followed by a unit qualifier and the quantity

Package 68788-4077-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 17, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Diuretics such as chlorthalidone are indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effect of other antihypertensive drugs in the more severe forms of hypertension. Chlorthalidone is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. Chlorthalidone has also been found useful in edema due to various forms of renal dysfunction, such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. Usage in Pregnancy The routine use of diuretics in an otherwise healthy woman is inappropriate and exposes mother and fetus t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 211627

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211627
Product	Strength	Form · route	Labeler	Product NDC
Chlorthalidone	Chlorthalidone 25 mg/1	TabletOral	Direct_Rx	72189-356
Chlorthalidone	Chlorthalidone 50 mg/1	TabletOral	Bryant Ranch Prepack	71335-3089
Chlorthalidone	Chlorthalidone 25 mg/1	TabletOral	Bryant Ranch Prepack	71335-1829
Chlorthalidone	Chlorthalidone 25 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-333
Chlorthalidone	Chlorthalidone 50 mg/1	TabletOral	Unichem Pharmaceuticals (USA), Inc.	29300-334